Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis

Abstract

AD was safe and efficacious during the study period in the majority of patients. However, vigilance is required for the early detection of severe and potentially fatal infections. AD may control recurrent uveitis and radiological progression.